Capital Fund Management S.A. Lowers Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• Capital Fund Management S.A. has reduced its holdings in GE HealthCare Technologies Inc. by 57.3%, selling 60,001 shares, and retains 44,715 shares valued at approximately $3.6 million.
• Analysts have mixed views on the stock, with Citigroup raising its target price to $93 while Morgan Stanley and Goldman Sachs have lowered their estimates, indicating varying opinions on its performance.
• GE HealthCare Technologies reported better-than-expected earnings with an EPS of $1.06 for the last quarter, exceeding analysts' expectations and showing a 3.5% revenue increase compared to the previous year.

Capital Fund Management S.A. lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 57.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,715 shares of the company's stock after selling 60,001 shares during the period. Capital Fund Management S.A.'s holdings in GE HealthCare Technologies were worth $3,609,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. N.E.W. Advisory Services LLC bought a new position in shares of GE HealthCare Technologies in the 1st quarter valued at about $25,000. Bogart Wealth LLC lifted its stake in shares of GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after buying an additional 247 shares during the last quarter. Stonebridge Financial Group LLC lifted its stake in shares of GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after buying an additional 222 shares during the last quarter. LGT Financial Advisors LLC lifted its stake in shares of GE HealthCare Technologies by 46.2% during the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock worth $30,000 after buying an additional 123 shares during the last quarter. Finally, Accredited Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth about $30,000. Institutional investors own 82.06% of the company's stock.

Analyst Ratings Changes

GEHC has been the subject of a number of research reports. Evercore ISI cut their target price on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating for the company in a research note on Thursday, May 1st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. UBS Group upgraded shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and dropped their target price for the company from $74.00 to $73.00 in a research report on Monday, May 5th. Wall Street Zen upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. Finally, Citigroup boosted their target price on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of "Moderate Buy" and an average price target of $88.55.

GE HealthCare Technologies Stock Down 0.3%

Shares of NASDAQ GEHC traded down $0.21 during trading on Friday, hitting $73.51. The stock had a trading volume of 382,958 shares, compared to its average volume of 3,960,424. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The company has a market capitalization of $33.56 billion, a PE ratio of 15.06, a PEG ratio of 2.84 and a beta of 1.13. The firm has a fifty day moving average of $74.18 and a two-hundred day moving average of $74.85.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the prior year, the business posted $1.00 EPS. The business's revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were given a dividend of $0.035 per share. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio is presently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.